Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mardi, novembre 17
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Medicus Pharma Ltd
MDCX
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$1.53
-0.16
-9.47%
Dern. MÀJ: Nov 17, 2:00 PM
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Medicus Pharma Financials
Medicus Pharma (MDCX) financial statements — income, revenue, gross margin and key metrics.
PRO
Pourquoi cela bouge-t-il ?:
Medicus Pharma shares are trading lower. The company announced the closing ...
Earnings & Guidance News
PRO
Medicus Pharma Q3 EPS $(11.64) Misses $(6.63) Estimate
Medicus Pharma (NASDAQ:MDCX) reported quarterly losses of $(11.64) per share which missed the analyst consensus estimate of $(6.63) by 75.83 percent. This is a 79.21 percent increase over losses of $(56.00) per share
Benzinga Newsdesk
PRO
Medicus Pharma Q2 EPS $(0.21) Misses $(0.13) Estimate
Medicus Pharma (NASDAQ:MDCX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.13) by 61.54 percent. This is a 51.16 percent increase over losses of $(0.43) per share from
Benzinga Newsdesk
PRO
Medicus Pharma Q1 EPS $(0.31) Misses $(0.19) Estimate
Medicus Pharma (NASDAQ:MDCX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.19) by 63.16 percent. This is a 26.19 percent increase over losses of $(0.42) per share from
Benzinga Newsdesk
PRO
Medicus Pharma Q4 EPS $(0.83) Misses $(0.15) Estimate
Medicus Pharma (NASDAQ:MDCX) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.15) by 442.48 percent.
Benzinga Newsdesk
PRO
Medicus Pharma Q3 EPS $(1.12) Misses $(0.29) Estimate
Medicus Pharma (NASDAQ:MDCX) reported quarterly losses of $(1.12) per share which missed the analyst consensus estimate of $(0.29) by 286.21 percent. This is a 366.67 percent decrease over losses of $(0.24) per share
Benzinga Newsdesk
Nasdaq Down 100 Points; Chicago PMI Dips In May
Avi Kapoor